Wexford Capital’s Evolus EOLS Stock Holding History

Wexford Capital’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,965	Closed	-$36.6K	–	421
2025 Q3	$36.6K	Buy	+5,965	New	+$46.5K	0.01%	341
2021 Q1	–	Sell	-9,261	Closed	-$31K	–	249
2020 Q4	$31K	Buy	+9,261	New	+$34.8K	﹤0.01%	293

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wexford Capital's EOLS Position: Q4 2025 in Review

Wexford Capital sold out of Evolus (EOLS) in Q4 2025, closing a stake of 5,965 shares — an estimated $36.6K sold.

Wexford Capital first reported a position in EOLS in Q4 2020 and held it in 2 quarters. The position peaked at $36.6K in Q3 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

Wexford Capital reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
Wexford Capital sold 5,965 Evolus shares in Q4 2025, an estimated $36.6K.
Wexford Capital first reported a position in Evolus in Q4 2020 and held it in 2 quarters.
Wexford Capital's Evolus position peaked at $36.6K in Q3 2025.
169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Wexford Capital's 13F filing for Q4 2025, filed 13 Feb 2026.